Linton, however, still appears confident in Canopy’s future. “[Canopy] continues to execute on the emerging opportunity for increasingly sophisticated global and national recreational and medical products. This is a vision and dedication exercise that is designed to reward shareholders over a huge and rapidly emerging market,” he said. “August has always been a buying opportunity.”